- Man arrested in car bomb plot at Kansas airport
- Prison inmates take up ‘Knockout’ game, target female officers
- U.S. Army hails success with drone-shooting laser
- John Kerry: Israel-Palestinian peace deal paved for April
- India diplomat who touts women’s rights busted for $3 wage to nanny
- MSNBC host Ed Schultz paid $252K by unions in 2012-2013
- Korean War memorial ordered to take down Christian cross
- Billy Graham near death, ‘close to going home to be with the Lord’
- SeaTac, Wash.: City’s new $15 minimum wage heads to court
- Obama mulls support for Islamists in Syria, with conditions
FDA: No warning required for nicotine gum, patches
The Food and Drug Administration said Monday that manufacturers of products designed to help people quit smoking can alter or remove previously required safety warnings that may be discouraging people from trying to kick the habit.
Specifically, the agency said it is no longer necessary to tell consumers they should not be using a nicotine replacement therapy product such as gum, the patch or lozenges if they are also still smoking, chewing tobacco, using snuff or another product that contains nicotine.
If a smoker were to “slip up” and use a cigarette while trying to quit with an NRT product, he should still continue to use the NRT, the agency says. Public health officials had told the FDA that some smokers would quit using them after a relapse, fearing the health risks from the warnings.
“FDA hopes the recommended changes will allow more people to use these products effectively for smoking cessation and that tobacco dependence will decline in this country,” FDA Commissioner Margaret Hamburg said.
The agency also said that while consumers should use the gum, patch or lozenges for the recommended amount of time, typically 8-12 weeks, it is acceptable to use them for longer if needed and if done under consultation with a doctor.
The agency said there was limited data available on use of NRT products when they hit the market 30 years ago as prescription-only items. Consumers could begin buying them over the counter in the late 1990s.
But extensive research shows the products contain a controlled supply of nicotine intended to reduce withdrawal symptoms and “do not appear to have significant potential for abuse or dependence,” according to the FDA.
FDA officials indicated they wanted to remove the warnings so smokers would not be dissuaded from quitting. According to the agency, about 45 million Americans smoke and tobacco use is responsible for about 440,000 deaths per year in the U.S..
The FDA said companies still will need to submit their new warnings to the agency for approval.
GlaxoSmithKline said in a statement that it expects to send to the FDA new labels for its popular Nicorette gum and NicoDerm patches “as soon as possible.”
The company “commends the FDA on this action and believes this is a positive step to help more smokers quit.”
© Copyright 2013 The Washington Times, LLC. Click here for reprint permission.
About the Author
Tom Howell Jr. covers politics for The Washington Times. He can be reached at email@example.com.
- In rare bipartisan move, Congress tackles long-standing Medicare issue
- White House improvises again on patchy Obamacare rollout
- Key Obamacare official: Last two months much harder than anyone hoped
- HHS Secretary Kathleen Sebelius calls for review of Obamacare rollout woes
- More than a quarter million sign up for Obamacare in November
Latest Blog Entries
- Calif.: Give 'gift of health' by pledging cash for the uninsured
- Tensions hit boiling point over Obamacare enrollment figures, error rates
- Young, uninsured adults vital to Obamacare are not keen on enrolling: New Harvard poll
- Paul Bunyan and Babe the Blue Ox will promote Obamacare at Mall of America
- HealthCare.gov employs a new look once again
By Mangosuthu Buthelezi
Memories of a long brotherhood tempered in common struggle
- U.S. Navy-China showdown: Chinese try to halt U.S. cruiser in international waters
- Obama birther theories float as Hawaii health director killed in crash
- House budget bargain faces Senate filibuster; Republicans line up to oppose
- PRUDEN: The last living witnesses; they wore the yellow star and remember the Nazi terror
- Obama's Afghanistan experts stumped on U.S. death toll, war costs during hearing
- North Korea's official report on Jang Song Thaek
- Billy Graham near death, close to going home to be with the Lord
- NAPOLITANO: A conspiracy so vast
- James Bond: The spy who is really an alcoholic
- U.S. pilot scares off Iranians with 'Top Gun'-worthy stunt: 'You really ought to go home'
Independent voices from the The Washington Times Communities
Our Choice: Individual responsibility and self-government or the abandonment of the American Revolution
A stat-head’s outlook, direct from his worn in couch cushion.
John Glaser turns his pen toward foreign policy and international relations around the world
A conservative commentator and satirist takes on the worlds of politics and entertainment in pursuit of truth, justice and all things America.
Extraordinary day at Redskins Park
White House pets gone wild!
Let it snow